Navigation Links
Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
Date:9/28/2011

is the most common form of male sexual dysfunction (four times the number with ED) with an estimated 23% of males suffering from this condition. The impact on the quality of life for these men and their partners can be profound. Behavioral therapy is the current standard of care for treatment of PE.

About Ampio

Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. The product pipeline includes new uses for previously approved drugs and new molecular entities ("NMEs"). By concentrating on development of new uses for previously approved drugs, approval timelines, costs and risk of clinical failure are reduced because these drugs have strong potential to be safe and effective while their shorter development times can significantly increase near term value. A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize Ampio's product development programs. For more information about Ampio, please visit our website, www.ampiopharma.com.

Forward-Looking Statements

Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include risks associated with clinical trials, expected results, regulatory approvals, future intellectual property rights, successful commercialization and marketing of Zertane™ and combination drugs, succe
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.
2. Champions Oncology Reports Fiscal 2012 First Quarter Financial Results
3. Ampio Pharmaceuticals Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane™ in South Korea
4. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
5. Ampio Pharmaceuticals, Inc. Releases Results From Phase III Clinical Trial of Zertane™ for the Treatment of Premature Ejaculation (PE), the Most Prevalent Form of Male Sexual Dysfunction
6. Ampio Pharmaceuticals Set to Join Russell 3000 Index
7. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
8. Ampio Pharmaceuticals, Inc. to Begin Trading on the NASDAQ Capital Market
9. Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market
10. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
11. Champions Biotechnology Exercises Option to License Proprietary Compound Based on Successful Tumorgraft™ Test Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... DALLAS , March 2, 2015 ... Industry 2015 Market Research Report of 178 pages ... online business intelligence library. The 2015 ... industry is a professional and deep research report ... analysis, the report introduces Angiographic X-ray System basic ...
(Date:3/1/2015)... 1, 2015 /CNW Telbec/ -   Ergoresearch Ltd (TSXV: ... and known under the « Équilibre, orthèses et ... quarter Ended on December 31, 2014. All dollar amounts ... Revenues for the second quarter of fiscal ... $ 4 095 112 decreasing by 8,8 % compared to revenues of ...
(Date:3/1/2015)... , March 1, 2015  An innovative interventional ... migraine sufferers sustained relief of their headaches, according ... of Interventional Radiology ,s Annual Scientific Meeting ... State University New York Empire State College in ... sphenopalatine ganglion (SPG) blocks to give patients enough ...
Breaking Medicine Technology:Global Angiographic X-ray System Industry Research Report 2Global Angiographic X-ray System Industry Research Report 3Global Angiographic X-ray System Industry Research Report 4Global Angiographic X-ray System Industry Research Report 5Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 3Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 4Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4
... be needed to achieve desired anticoagulant effect in some ... October 8 , SILVER SPRING, Md., Oct. 1 ... health care professionals to a change in heparin manufacturing ... common blood-clotting drug. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , ...
... Accuray Incorporated (Nasdaq: ARAY ), a global leader ... results from a study of early stage prostate cancer ... erectile function was preserved in 81 percent of patients ... of erectile function preservation at two years for other ...
Cached Medicine Technology:FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency 2FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 4
(Date:3/1/2015)... 01, 2015 “ The Barrel Mill ” ... Report, which takes a look at the latest and coolest ... host of NewsWatch and a technology expert, conducted the review ... flavor to drinks. , According to Home Distillation of Alcohol, ... spirits. Well, there’s a pretty cool product that’ll help anyone ...
(Date:2/28/2015)... 28, 2015 The MCA Youth Empowerment ... into one platform and gears towards the goal for ... series of group talks in smaller groups will be ... Education, Personal Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, ... of Malaysian youths. , Young adults aged ...
(Date:2/28/2015)... 28, 2015 In a recent episode ... of Game Change Athlete Development Services and ... the benefits of athlete development and player engagement during ... unique challenges that athletes face and how off-field activities ... , Fletcher became involved in athlete development issues while ...
(Date:2/28/2015)... February 28, 2015 The Heart Fit ... a distributor of the machine. The Heart Fit Clinic ... license, like a franchise model. The goal is to ... reverse heart disease. To buy External Counterpulsation ... can help individuals through this process and achieve the ...
(Date:2/28/2015)... Vancouver, BC (PRWEB) February 28, 2015 ... has recently announced that they now provide business consulting ... services, such as corporate tax planning and succession planning. ... be entrusted to experienced professionals. On top of this, ... difficult to handle corporate accounting. As a result, Mew ...
Breaking Medicine News(10 mins):Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2
... Martha J. Farah, Professor of Psychology, Annenberg ... Center for Cognitive Neuroscience, University of Pennsylvania ... and Brain Development,part of the symposium Poverty ... Implications at the 2008 American Association for ...
... ductal carcinoma in situ will not spread, researchers say , , ... a precancerous breast lesion known as ductal carcinoma in situ ... face a low risk of a recurrence or of developing ... these women are living as if they,re waiting for the ...
... , , TUESDAY, Feb. 12 (HealthDay News) -- Americans are spending ... new research suggests those extra dollars aren,t buying more relief. ... of a study in the Feb. 13 issue of the ... lack of results weren,t. , "This calls into question whether ...
... Race Updated for Top Auction Lot, Benefiting Elton John,s ... NEW YORK, Feb. 12 It was 80 years ... and The Leading,Hotels of the World, Ltd. And to ... the adventure, romance and excitement that made the,Academy Award-winning ...
... (PHILADELPHIA) Liver cancer specialists at Jeffersons Kimmel Cancer Center ... new treatment for liver cancer. The therapy entails injecting ... the livers main artery while also blocking the blood ... radioembolization, has been approved by the federal Food and ...
... for the 2008-2009 Academic Year Are Now,Available, ... of Nursing (AACN) and the Johnson & Johnson ... the first five Minority Nurse,Faculty Scholars have been ... shortage of nurse educators. This program was launched ...
Cached Medicine News:Health News:Precancerous Breast Lesions Cause Unnecessary Worry 2Health News:Precancerous Breast Lesions Cause Unnecessary Worry 3Health News:Precancerous Breast Lesions Cause Unnecessary Worry 4Health News: Back Pain Spending Up, Relief Down 2Health News: Back Pain Spending Up, Relief Down 3Health News:The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways 2Health News:The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways 3Health News:The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways 4Health News:The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways 5Health News:New Jefferson trial to test radiation-emitting beads against advanced liver cancer 2Health News:First Group of Minority Nurse Faculty Scholars Selected by the Johnson & Johnson Campaign for Nursing's Future and AACN 2Health News:First Group of Minority Nurse Faculty Scholars Selected by the Johnson & Johnson Campaign for Nursing's Future and AACN 3
... The Infinity Uric Acid single liquid ... the convenience of single liquid stability ... operator error and provide quick result ... the Infinity Uric Acid reagent provides ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
... Creatinine single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... reagent provides a long shelf life ...
... practice by seeing more patients per day. Utilizing ... turn a 14-18 patients per day practice into ... automated test sequences, youll perform accurate refractions in ... learn; making it easy to delegate tasks to ...
Medicine Products: